Activity Provided By:

ACHL

From Risk Assessment to Treatment: Real-World Approaches to PAH

Overview / Abstract:	In this clinical commentary, join cardiology expert Dr. Vallerie McLaughlin, Director of the Pulmonary Hypertension Program at the University of Michigan and pulmonology expert Dr. Victor Tapson, Director, Pulmonary Vascular Disease Research at Cedars-Sinai Medical Center as they provide real-world advice on the management of pulmonary arterial hypertension (PAH). These experts will discuss their best practices for: • Risk assessment and stratification • Use of oral combination therapies • Management of PAH patients during COVID-19 Dr. McLaughlin and Dr. Tapson also provide their insights into the future of PAH management, with a discussion of emerging therapeutic options. You can find the comprehensive PAH online learning destination here: www.carePAHthways.com.
Expiration	Jul 14, 2022
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME, Respiratory Therapy CE
Format	Webinar / Webcast / Video
Credits / Hours	0.75
Accreditation	ACCME
Presenters / Authors / Faculty	Vallerie McLaughlin, MD Kim A. Eagle MD Endowed Professor of Cardiovascular Medicine Director of the Pulmonary Hypertension Program University of Michigan Ann Arbor, MI Victor Tapson, MD Professor of Medicine Director, Venous Thromboembolism Research Director, Clinical Research, Women’s Guild Lung Institute Associate Director, Division of Pulmonary and Critical Care Director, Pulmonary Vascular Disease Research Cedars-Sinai Medical Center Los Angeles, CA
Activity Specialities / Related Topics	Cardiology / Cardiovascular, Emergency Medicine, Family Medicine, Internal Medicine, Primary Care, Pulmonary Medicine / COPD
Sponsors / Supporters / Grant Providers	Sponsored by the Academy for Continued Healthcare Learning (ACHL). Supported by an educational grant from Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson
Keywords / Search Terms	ACHL CME, Continuing Medical Education, PAH, Pulmonary Arterial Hypertension (PAH), Dr. Vallerie McLaughlin, Dr. Victor Tapson, Cedars-Sinai Medical Center, University of Michigan, Actelion, 6th World Symposium on Pulmonary Hypertension, CHEST Guidelines, 2015 ESC/ERS guidelines, AMBITION trial, OPTIMA, macitentan, tadalafil, TRITON, PRACMA, PDE5 inhibitor, prostacyclin, INCREASE trial, COVID-19, telemedicine Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map